Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 594
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2301GAPDRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 5.27) and (ratio of HBV-HCC v/s HCV-HCC 0.29) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2302CD58RNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 4.68) and (ratio of HBV-HCC v/s HCV-HCC 0.31) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2303CD24RNAsHumanUpregulated in the high-risk group PrognosticEarly recurrence of HCC v/s Late recurrence of HCC p < 0.001Tissue18381945
2304CLDN10RNAsHumanUpregulated in Cirrhosis v/s control and early and advanced HCC DiagnosticCirrhosis v/s Low/High grade dysplastic nodules, normal and early/Late HCC p < 0.05Tissue17393520
2305GREM2RNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2306EPORNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2307NRG1RNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2308ASPMRNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2309PRIM1RNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2310HMMRRNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2311IRAK1RNAsHumanUpregulated in early/advanced HCC v/s control and dysplasia Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520
2312C/EBPRNAsHumanDownregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2313HNF-1RNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2314HNF-3betaRNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2315HNF-4alphaRNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2316HNF-4gammaRNAsHumanUpregulated in cancer DiagnosticHCC v/s non-tumor HCC NATissue11306505
2317NDRG2Protein and RNAsHumanDownregulated in HCC than non-tumor Diagnostic and PrognosticHCC v/s cirrhosis/healthy/non-tumor HCC; associated with recurrence and tumor grade p < 0.05Tissue18519680
2318CSTBProtein and RNAsHumanUpegulated in HCC than non-tumor DiagnosticHCC v/s cirrhosis/healthy/non-tumor HCC p < 0.05Serum18281540
2319AFPProteinHumanUpegulated in HCC than non-tumor DiagnosticHCC v/s cirrhosis/healthy/non-tumor HCC p < 0.05Serum18281540
2320CSTB, AFPProteinHumanUpegulated in HCC than non-tumor DiagnosticHCC v/s cirrhosis/healthy/non-tumor HCC p < 0.05Serum18281540
2321TGF betaRNAsHumanUpegulated in HCC than non-tumor Prognosticearly occurrence v/s late recurrence NATissue20380719
2322MycRNAsHumanUpegulated in HCC than non-tumor Prognosticearly occurrence v/s late recurrence NATissue20380719
2323LOC388796, A_32_P406142, SAFB, MKL1, TNKS1BP1, PMM2, PPP2R5C, SAFB2, GATA4, RASD1, KIAA1967,RNAsHumanover expressed in subjects with fastest recurrence Prognosticearly occurrence v/s late recurrence p < 0.0001Tissue20380719
2324ID2Protein and RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.4) PrognosticHCC with PVI v/s HCC without PVI p < 0.005Tissue17088983
2325API5RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.49) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2326CTAG1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.36) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2327NOLA2RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.34) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2328DKFZP566D193RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.3) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2329IMMTRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.3) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2330DDX1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.16) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2331NUDCRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2332HT010RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2333RANRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2334PDHBRNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.13) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2335SCA1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.12) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2336PTENP1RNAsHumanUpregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.11) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2337HFL3RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 2.0) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2338PMS2L11RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.83) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2339SGKRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.64) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2340GPRK6RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.59) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2341ZNF216RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.54) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2342TIAL1RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.53) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2343KIAA0564RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.48) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2344GADD45BRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.41) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2345TAPBPRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.35) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2346RHO6RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.25) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2347SLC9A3R2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2348HFL1RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2349CG018RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.23) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2350PIK3R1RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.22) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top